Bionano Genomics (BNGO) Assets Average (2018 - 2026)

Bionano Genomics has disclosed Assets Average across 9 years of filings, most recently posting $69.2 million for Q1 2026.

• Assets Average for Q1 2026 came in at $69.2 million, down 10.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $69.2 million (down 10.77% YoY), and the FY2025 annual result was $75.1 million, down 48.38% from the prior year.
• Assets Average came in at $69.2 million for Q1 2026 at Bionano Genomics, down from $76.3 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $362.7 million in Q1 2022 to a low of $69.2 million in Q1 2026.
• The 5-year median for Assets Average is $186.2 million (2024), against an average of $190.6 million.
• Across the five-year window, Assets Average surged 62.88% in 2022 and sank 58.61% in 2024, its largest moves.
• Bionano Genomics' Assets Average stood at $315.6 million in 2022, then sank by 37.21% to $198.2 million in 2023, then plunged by 58.61% to $82.0 million in 2024, then declined by 6.94% to $76.3 million in 2025, then fell by 9.34% to $69.2 million in 2026.
• The last three Assets Average figures came in at $69.2 million (Q1 2026), $76.3 million (Q4 2025), and $77.5 million (Q3 2025), per Business Quant data.